» Articles » PMID: 3994582

Antiatherosclerotic Effects of Nicardipine and Nifedipine in Cholesterol-fed Rabbits

Overview
Date 1985 May 1
PMID 3994582
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Dutch-belted rabbits fed a 2% cholesterol diet for 8 weeks developed atherosclerotic lesions that covered 37.2% +/- 3.5% of the aortic luminal surface. In samples of aortic arch, accumulation of cholesterol and triglyceride was also observed. Oral administration of nicardipine or nifedipine at dosages of 40 mg/kg twice daily for 8 weeks reduced plaque area by 49.2% and 58.7%, respectively. Nicardipine and nifedipine reduced cholesterol accumulation in the aortic arch by 74.5% and 69%, respectively. Triglyceride accumulation was totally abolished. Neither drug significantly altered cholesterol concentration of plasma low density lipoprotein or high density lipoprotein, although nicardipine produced a 42% reduction in cholesterol concentration of the d less than 1.006 g/ml fraction. The above results suggest potential therapeutic utility of nicardipine in atherosclerosis.

Citing Articles

Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.

Matsumura T, Taketa K, Shimoda S, Araki E J Diabetes Investig. 2014; 3(1):11-23.

PMID: 24843540 PMC: 4014927. DOI: 10.1111/j.2040-1124.2011.00182.x.


eNOS-dependent antisenscence effect of a calcium channel blocker in human endothelial cells.

Hayashi T, Yamaguchi T, Sakakibara Y, Taguchi K, Maeda M, Kuzuya M PLoS One. 2014; 9(2):e88391.

PMID: 24520379 PMC: 3919771. DOI: 10.1371/journal.pone.0088391.


Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities.

Sinno M, Al-Mallah M Cardiol Res Pract. 2010; 2010:134564.

PMID: 20672024 PMC: 2909714. DOI: 10.4061/2010/134564.


Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.

Dens J, Desmet W, Coussement P, De Scheerder I, Kostopoulos K, Kerdsinchai P Heart. 2003; 89(8):887-92.

PMID: 12860866 PMC: 1767780. DOI: 10.1136/heart.89.8.887.


Modulation by dihydropyridine-type calcium channel antagonists of cytokine-inducible gene expression in vascular smooth muscle cells.

Cattaruzza M, Wachter R, Wagner A, Hecker M Br J Pharmacol. 2000; 129(6):1155-62.

PMID: 10725264 PMC: 1571958. DOI: 10.1038/sj.bjp.0703192.